For laboratory research use only · Not for human consumption
Free shipping on orders over $200
PEP-TIRZ COA verifiedRUO

Tirzepatide

$159.00

A dual GIP and GLP-1 receptor agonist peptide investigated in metabolic research.

Purity
≥99%
Mol. weight
4813.5 g/mol
CAS
2023788-19-2
Form
Lyophilized powder
Bundle & Save Buy more, save more — pricing applied automatically.
Complete your research kit Frequently added together
Order total$159.00
  • HPLC verified
  • Batch COA
  • Cold-packed
  • Ships in 24h
This product is intended for laboratory research use only. Not for human or animal consumption.

SKU: PEP-TIRZ

A dual GIP and GLP-1 receptor agonist peptide investigated in metabolic research.

Tirzepatide is supplied at ≥99% purity as verified by HPLC, with identity confirmed by mass spectrometry. Every vial is labelled with a lot number traceable to its Certificate of Analysis.

Information provided for laboratory research reference only.

Description

A dual GIP and GLP-1 receptor agonist peptide investigated in metabolic research.

Each lot is synthesised by solid-phase peptide synthesis, purified by preparative HPLC and released only after independent analytical testing. Supplied as a lyophilized powder in a sealed glass vial.

For laboratory research use only. Not for human or veterinary use.

Tirzepatide is used by investigators in the following research areas:

  • Dual incretin receptor research
  • Insulin secretion assays
  • Lipid metabolism models

Information provided for laboratory research reference only.

Tirzepatide is a 39-amino-acid peptide engineered to activate both GIP and GLP-1 receptors. A C20 fatty-diacid moiety supports albumin binding and prolonged activity in research models.

Information provided for laboratory research reference only.

  • Dual-receptor activity in one compound
  • Extended half-life
  • Batch-level identity confirmation by MS

Information provided for laboratory research reference only.

Tirzepatide has been examined in a body of peer-reviewed preclinical literature. Researchers should consult primary sources for study design, models and findings.

Referenced literature is provided for scientific context only and does not imply suitability for any use outside the laboratory.

Information provided for laboratory research reference only.

Compound Information

Chemical identity and handling data

TirzepatideC225H348N48O68
Purity≥99%
Molecular formulaC225H348N48O68
Molecular weight4813.5 g/mol
CAS number2023788-19-2
Purity≥99%
Amount per vial10 mg
FormLyophilized powder
AppearanceWhite to off-white powder
SolubilityWater, bacteriostatic water
Storage-20°C, desiccated, protected from light
Peptide classGIP/GLP-1 dual agonist

Certificate of Analysis

Independent batch testing results

Every batch is independently tested. Match the lot number printed on your vial with the certificate below.

LOT PS-2370 PASS
Purity
99.10%
Tested
September 28, 2026
Method
HPLC / ESI-MS
Mass
4813.5 Da
Independent Analytical Laboratory
LOT PS-2170 PASS
Purity
99.50%
Tested
July 10, 2026
Method
HPLC / ESI-MS
Mass
4813.5 Da
Independent Analytical Laboratory

Open the full COA library →

Reconstitution Calculator

Plan concentration and syringe units for this vial

Concentration—mcg / mL
Volume to draw—mL
Syringe units—units (U-100)
Doses per vial—doses

Calculators are provided for laboratory research planning only and do not constitute medical advice.

Frequently Asked Questions

Handling, storage and documentation

Q01How should Tirzepatide be stored?

Store the lyophilized vial at -20°C, protected from light and moisture. After reconstitution, keep refrigerated at 2–8°C and use within the timeframe appropriate to your protocol.

Q02How do I reconstitute the vial?

Allow the vial to reach room temperature, then slowly add bacteriostatic water down the side of the vial and swirl gently — do not shake. Use our reconstitution calculator to plan concentrations.

Q03Where can I find the COA for my vial?

Match the lot number printed on your vial label with the certificate in the COA tab or in our COA library.

Researcher Reviews

Feedback from verified buyers

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *